From Molecular Shape to Potent Bioactive Agents II: Fragment‐Based de novo Design

Abstract

Fragment-based drug design: Computer-assisted molecular design has emerged as a valuable tool for lead discovery. We present the successful de novo design, synthesis, and testing of a PPAR agonist using a novel fragment-based compound assembly strategy.